FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000978761> ?p ?o ?g. }

• W2000978761 endingPage "e968" @default.
• W2000978761 startingPage "e968" @default.
• W2000978761 abstract "Background A wide spectrum of disease severity has been described for Human African Trypanosomiasis (HAT) due to Trypanosoma brucei rhodesiense (T.b. rhodesiense), ranging from chronic disease patterns in southern countries of East Africa to an increase in virulence towards the north. However, only limited data on the clinical presentation of T.b. rhodesiense HAT is available. From 2006-2009 we conducted the first clinical trial program (Impamel III) in T.b. rhodesiense endemic areas of Tanzania and Uganda in accordance with international standards (ICH-GCP). The primary and secondary outcome measures were safety and efficacy of an abridged melarsoprol schedule for treatment of second stage disease. Based on diagnostic findings and clinical examinations at baseline we describe the clinical presentation of T.b. rhodesiense HAT in second stage patients from two distinct geographical settings in East Africa. Methodology/Principal Findings: 138 second stage patients from Tanzania and Uganda were enrolled. Blood samples were collected for diagnosis and molecular identification of the infective trypanosomes, and T.b. rhodesiense infection was confirmed in all trial subjects. Significant differences in diagnostic parameters and clinical signs and symptoms were observed: the median white blood cell (WBC) count in the cerebrospinal fluid (CSF) was significantly higher in Tanzania (134cells/mm3) than in Uganda (20cells/mm3; p<0.0001). Unspecific signs of infection were more commonly seen in Uganda, whereas neurological signs and symptoms specific for HAT dominated the clinical presentation of the disease in Tanzania. Co-infections with malaria and HIV did not influence the clinical presentation nor treatment outcomes in the Tanzanian study population. Conclusions/Significance We describe a different clinical presentation of second stage T.b. rhodesiense HAT in two distinct geographical settings in East Africa. In the ongoing absence of sensitive diagnostic tools and safe drugs to diagnose and treat second stage T.b. rhodesiense HAT an early identification of the disease is essential. A detailed understanding of the clinical presentation of T.b. rhodesiense HAT among health personnel and affected communities is vital, and awareness of regional characteristics, as well as implications of co-infections, can support decision making and differential diagnosis." @default.
• W2000978761 created "2016-06-24" @default.
• W2000978761 creator A5013205553 @default.
• W2000978761 creator A5028142124 @default.
• W2000978761 creator A5045602386 @default.
• W2000978761 creator A5047112094 @default.
• W2000978761 creator A5088201034 @default.
• W2000978761 creator A5090819340 @default.
• W2000978761 date "2011-03-01" @default.
• W2000978761 modified "2023-09-23" @default.
• W2000978761 title "Clinical Presentation of T.b. rhodesiense Sleeping Sickness in Second Stage Patients from Tanzania and Uganda" @default.
• W2000978761 cites W1550533503 @default.
• W2000978761 cites W1578476449 @default.
• W2000978761 cites W1583213794 @default.
• W2000978761 cites W1872635597 @default.
• W2000978761 cites W1966220751 @default.
• W2000978761 cites W1979679940 @default.
• W2000978761 cites W1980815549 @default.
• W2000978761 cites W1980979493 @default.
• W2000978761 cites W1981629041 @default.
• W2000978761 cites W1988477462 @default.
• W2000978761 cites W1999562946 @default.
• W2000978761 cites W2002241467 @default.
• W2000978761 cites W2027110135 @default.
• W2000978761 cites W2036763008 @default.
• W2000978761 cites W2037204625 @default.
• W2000978761 cites W2047023623 @default.
• W2000978761 cites W2054215205 @default.
• W2000978761 cites W2057442624 @default.
• W2000978761 cites W2067458263 @default.
• W2000978761 cites W2077351040 @default.
• W2000978761 cites W2090902980 @default.
• W2000978761 cites W2104697879 @default.
• W2000978761 cites W2104765579 @default.
• W2000978761 cites W2113295439 @default.
• W2000978761 cites W2114288993 @default.
• W2000978761 cites W2122053924 @default.
• W2000978761 cites W2151799620 @default.
• W2000978761 cites W2157068523 @default.
• W2000978761 cites W2163584625 @default.
• W2000978761 cites W2165088771 @default.
• W2000978761 cites W2165320275 @default.
• W2000978761 cites W2170702416 @default.
• W2000978761 cites W2171542897 @default.
• W2000978761 cites W2326311620 @default.
• W2000978761 cites W2406133823 @default.
• W2000978761 cites W2442817961 @default.
• W2000978761 cites W4243531181 @default.
• W2000978761 cites W4250713400 @default.
• W2000978761 cites W4300629032 @default.
• W2000978761 doi "https://doi.org/10.1371/journal.pntd.0000968" @default.
• W2000978761 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3046969" @default.
• W2000978761 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21407802" @default.
• W2000978761 hasPublicationYear "2011" @default.
• W2000978761 type Work @default.
• W2000978761 sameAs 2000978761 @default.
• W2000978761 citedByCount "51" @default.
• W2000978761 countsByYear W20009787612012 @default.
• W2000978761 countsByYear W20009787612013 @default.
• W2000978761 countsByYear W20009787612014 @default.
• W2000978761 countsByYear W20009787612015 @default.
• W2000978761 countsByYear W20009787612016 @default.
• W2000978761 countsByYear W20009787612017 @default.
• W2000978761 countsByYear W20009787612018 @default.
• W2000978761 countsByYear W20009787612019 @default.
• W2000978761 countsByYear W20009787612020 @default.
• W2000978761 countsByYear W20009787612021 @default.
• W2000978761 countsByYear W20009787612022 @default.
• W2000978761 countsByYear W20009787612023 @default.
• W2000978761 crossrefType "journal-article" @default.
• W2000978761 hasAuthorship W2000978761A5013205553 @default.
• W2000978761 hasAuthorship W2000978761A5028142124 @default.
• W2000978761 hasAuthorship W2000978761A5045602386 @default.
• W2000978761 hasAuthorship W2000978761A5047112094 @default.
• W2000978761 hasAuthorship W2000978761A5088201034 @default.
• W2000978761 hasAuthorship W2000978761A5090819340 @default.
• W2000978761 hasBestOaLocation W20009787611 @default.
• W2000978761 hasConcept C126322002 @default.
• W2000978761 hasConcept C187212893 @default.
• W2000978761 hasConcept C203014093 @default.
• W2000978761 hasConcept C2778143080 @default.
• W2000978761 hasConcept C2778792689 @default.
• W2000978761 hasConcept C2779357621 @default.
• W2000978761 hasConcept C2909346784 @default.
• W2000978761 hasConcept C39432304 @default.
• W2000978761 hasConcept C71924100 @default.
• W2000978761 hasConcept C91375879 @default.
• W2000978761 hasConceptScore W2000978761C126322002 @default.
• W2000978761 hasConceptScore W2000978761C187212893 @default.
• W2000978761 hasConceptScore W2000978761C203014093 @default.
• W2000978761 hasConceptScore W2000978761C2778143080 @default.
• W2000978761 hasConceptScore W2000978761C2778792689 @default.
• W2000978761 hasConceptScore W2000978761C2779357621 @default.
• W2000978761 hasConceptScore W2000978761C2909346784 @default.
• W2000978761 hasConceptScore W2000978761C39432304 @default.
• W2000978761 hasConceptScore W2000978761C71924100 @default.
• W2000978761 hasConceptScore W2000978761C91375879 @default.
• W2000978761 hasIssue "3" @default.

• next